The Real-World Utilization Pattern of Increased Utilization of Advanced Topical Adjunctive Hemostats in a Vertically Integrated Healthcare System
Hemostasis products, such as SURGICEL®, have been increasingly used across a wide variety of surgical procedures to mitigate bleeding-related risks and complications. This retrospective observational study described the utilization pattern of the SURGICEL® family of oxidized regenerated cellulose pr...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2017-01-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/9813 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823860377835798528 |
|---|---|
| author | Lee Stern Yi-Chien Lee Biwen Tao Lois Lamerato Gaurav Gangoli Richard Kocharian Walter Danker III |
| author_facet | Lee Stern Yi-Chien Lee Biwen Tao Lois Lamerato Gaurav Gangoli Richard Kocharian Walter Danker III |
| author_sort | Lee Stern |
| collection | DOAJ |
| description | Hemostasis products, such as SURGICEL®, have been increasingly used across a wide variety of surgical procedures to mitigate bleeding-related risks and complications. This retrospective observational study described the utilization pattern of the SURGICEL® family of oxidized regenerated cellulose products (SURGICEL® ORIGINAL, SURGICEL® FIBRILLAR™, SURGICEL SNoW®) in a large, vertically integrated healthcare system, by utilizing electronic medical records (EMR) extracted from August 2013 through June 2015 at Henry Ford Health System (HFHS). Descriptive measurements were compared between SURGICEL® ORIGINAL and advanced SURGICEL® products (SURGICEL® FIBRILLAR™ and SURGICEL SNoW®) for pooled common surgical procedures. Among 1471 patients, 450 received SURGICEL® ORIGINAL, and 1021 received advanced SURGICEL® products. A significantly greater proportion of patients given advanced SURGICEL® products had comorbidities (91.0% vs 85.6%, p=.0024), prior bleeding conditions (49.9% vs 30.9%, p<.0001), and prior use of anticoagulants (27.7% vs 5.3%, p<.0001). Advanced SURGICEL® products were more likely to be used in coronary artery bypass grafting (13.7% vs 1.6%, p<.0001). Among a sub-set of 1420 patients with complete package size information (988 Advanced and 432 ORIGINAL), significantly fewer mean normalized units of Advanced SURGICEL® were used per patient case (3.9 vs 5.5, p<.0001). Despite Advanced SURGICEL® products being utilized in higher risk bleeding situations compared to cases where SURGICEL® ORIGINAL was utilized, fewer overall normalized units of Advanced SURGICEL® were required per patient case. Further research is needed to investigate the implications of topical hemostat use in continuous oozing bleeding situations on outcomes, hospital costs, and resources. |
| format | Article |
| id | doaj-art-d602ae0c3ead474a840d8beae72539b1 |
| institution | Kabale University |
| issn | 2327-2236 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Columbia Data Analytics, LLC |
| record_format | Article |
| series | Journal of Health Economics and Outcomes Research |
| spelling | doaj-art-d602ae0c3ead474a840d8beae72539b12025-02-10T16:12:40ZengColumbia Data Analytics, LLCJournal of Health Economics and Outcomes Research2327-22362017-01-0142The Real-World Utilization Pattern of Increased Utilization of Advanced Topical Adjunctive Hemostats in a Vertically Integrated Healthcare SystemLee SternYi-Chien LeeBiwen TaoLois LameratoGaurav GangoliRichard KocharianWalter Danker IIIHemostasis products, such as SURGICEL®, have been increasingly used across a wide variety of surgical procedures to mitigate bleeding-related risks and complications. This retrospective observational study described the utilization pattern of the SURGICEL® family of oxidized regenerated cellulose products (SURGICEL® ORIGINAL, SURGICEL® FIBRILLAR™, SURGICEL SNoW®) in a large, vertically integrated healthcare system, by utilizing electronic medical records (EMR) extracted from August 2013 through June 2015 at Henry Ford Health System (HFHS). Descriptive measurements were compared between SURGICEL® ORIGINAL and advanced SURGICEL® products (SURGICEL® FIBRILLAR™ and SURGICEL SNoW®) for pooled common surgical procedures. Among 1471 patients, 450 received SURGICEL® ORIGINAL, and 1021 received advanced SURGICEL® products. A significantly greater proportion of patients given advanced SURGICEL® products had comorbidities (91.0% vs 85.6%, p=.0024), prior bleeding conditions (49.9% vs 30.9%, p<.0001), and prior use of anticoagulants (27.7% vs 5.3%, p<.0001). Advanced SURGICEL® products were more likely to be used in coronary artery bypass grafting (13.7% vs 1.6%, p<.0001). Among a sub-set of 1420 patients with complete package size information (988 Advanced and 432 ORIGINAL), significantly fewer mean normalized units of Advanced SURGICEL® were used per patient case (3.9 vs 5.5, p<.0001). Despite Advanced SURGICEL® products being utilized in higher risk bleeding situations compared to cases where SURGICEL® ORIGINAL was utilized, fewer overall normalized units of Advanced SURGICEL® were required per patient case. Further research is needed to investigate the implications of topical hemostat use in continuous oozing bleeding situations on outcomes, hospital costs, and resources.https://doi.org/10.36469/9813 |
| spellingShingle | Lee Stern Yi-Chien Lee Biwen Tao Lois Lamerato Gaurav Gangoli Richard Kocharian Walter Danker III The Real-World Utilization Pattern of Increased Utilization of Advanced Topical Adjunctive Hemostats in a Vertically Integrated Healthcare System Journal of Health Economics and Outcomes Research |
| title | The Real-World Utilization Pattern of Increased Utilization of Advanced Topical Adjunctive Hemostats in a Vertically Integrated Healthcare System |
| title_full | The Real-World Utilization Pattern of Increased Utilization of Advanced Topical Adjunctive Hemostats in a Vertically Integrated Healthcare System |
| title_fullStr | The Real-World Utilization Pattern of Increased Utilization of Advanced Topical Adjunctive Hemostats in a Vertically Integrated Healthcare System |
| title_full_unstemmed | The Real-World Utilization Pattern of Increased Utilization of Advanced Topical Adjunctive Hemostats in a Vertically Integrated Healthcare System |
| title_short | The Real-World Utilization Pattern of Increased Utilization of Advanced Topical Adjunctive Hemostats in a Vertically Integrated Healthcare System |
| title_sort | real world utilization pattern of increased utilization of advanced topical adjunctive hemostats in a vertically integrated healthcare system |
| url | https://doi.org/10.36469/9813 |
| work_keys_str_mv | AT leestern therealworldutilizationpatternofincreasedutilizationofadvancedtopicaladjunctivehemostatsinaverticallyintegratedhealthcaresystem AT yichienlee therealworldutilizationpatternofincreasedutilizationofadvancedtopicaladjunctivehemostatsinaverticallyintegratedhealthcaresystem AT biwentao therealworldutilizationpatternofincreasedutilizationofadvancedtopicaladjunctivehemostatsinaverticallyintegratedhealthcaresystem AT loislamerato therealworldutilizationpatternofincreasedutilizationofadvancedtopicaladjunctivehemostatsinaverticallyintegratedhealthcaresystem AT gauravgangoli therealworldutilizationpatternofincreasedutilizationofadvancedtopicaladjunctivehemostatsinaverticallyintegratedhealthcaresystem AT richardkocharian therealworldutilizationpatternofincreasedutilizationofadvancedtopicaladjunctivehemostatsinaverticallyintegratedhealthcaresystem AT walterdankeriii therealworldutilizationpatternofincreasedutilizationofadvancedtopicaladjunctivehemostatsinaverticallyintegratedhealthcaresystem AT leestern realworldutilizationpatternofincreasedutilizationofadvancedtopicaladjunctivehemostatsinaverticallyintegratedhealthcaresystem AT yichienlee realworldutilizationpatternofincreasedutilizationofadvancedtopicaladjunctivehemostatsinaverticallyintegratedhealthcaresystem AT biwentao realworldutilizationpatternofincreasedutilizationofadvancedtopicaladjunctivehemostatsinaverticallyintegratedhealthcaresystem AT loislamerato realworldutilizationpatternofincreasedutilizationofadvancedtopicaladjunctivehemostatsinaverticallyintegratedhealthcaresystem AT gauravgangoli realworldutilizationpatternofincreasedutilizationofadvancedtopicaladjunctivehemostatsinaverticallyintegratedhealthcaresystem AT richardkocharian realworldutilizationpatternofincreasedutilizationofadvancedtopicaladjunctivehemostatsinaverticallyintegratedhealthcaresystem AT walterdankeriii realworldutilizationpatternofincreasedutilizationofadvancedtopicaladjunctivehemostatsinaverticallyintegratedhealthcaresystem |